BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 34383180)

  • 1. Hormone receptor-positive breast cancer and black race: does sex matter?
    Eskander MF; Li Y; Bhattacharyya O; Tsung A; Oppong BA; Hamad A; Gatti-Mays M; Obeng-Gyasi S
    Breast Cancer Res Treat; 2021 Nov; 190(1):111-119. PubMed ID: 34383180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Male breast cancer in the veterans affairs population: a comparative analysis.
    Nahleh ZA; Srikantiah R; Safa M; Jazieh AR; Muhleman A; Komrokji R
    Cancer; 2007 Apr; 109(8):1471-7. PubMed ID: 17342768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Poor prognosis of male triple-positive breast Cancer patients: a propensity score matched SEER analysis and molecular portraits.
    Wang B; Wang H; Zhao A; Zhang M; Yang J
    BMC Cancer; 2021 May; 21(1):523. PubMed ID: 33964913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hormone Receptor-Positive Breast Cancer Has a Worse Prognosis in Male Than in Female Patients.
    Li X; Yang J; Krishnamurti U; Huo L; Ward KC; O'Regan R; Peng L
    Clin Breast Cancer; 2017 Aug; 17(5):356-366. PubMed ID: 28576631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Prognostic Analysis of Male Breast Cancer (MBC) Compared with Post-Menopausal Female Breast Cancer (FBC).
    Yu XF; Yang HJ; Yu Y; Zou DH; Miao LL
    PLoS One; 2015; 10(8):e0136670. PubMed ID: 26313461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Men and women show similar survival outcome in stage IV breast cancer.
    Wu SG; Zhang WW; Liao XL; Sun JY; Li FY; Su JJ; He ZY
    Breast; 2017 Aug; 34():115-121. PubMed ID: 28577471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of Korean Male Breast Cancer Using an Online Nationwide Breast-Cancer Database: Matched-Pair Analysis of Patients With Female Breast Cancer.
    Choi MY; Lee SK; Lee JE; Park HS; Lim ST; Jung Y; Ko BK; Nam SJ;
    Medicine (Baltimore); 2016 Apr; 95(16):e3299. PubMed ID: 27100414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gender Disparity in Breast Cancer: A Veteran Population-Based Comparison.
    Aggarwal A; Adepoju B; Yacur M; Maron D; Sharma MC
    Clin Breast Cancer; 2021 Aug; 21(4):e471-e478. PubMed ID: 33619003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparing the Characteristics and Outcomes of Male and Female Breast Cancer Patients in Korea: Korea Central Cancer Registry.
    Lee EG; Jung SY; Lim MC; Lim J; Kang HS; Lee S; Han JH; Jo H; Won YJ; Lee ES
    Cancer Res Treat; 2020 Jul; 52(3):739-746. PubMed ID: 32054149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathologic characteristics and survival of male breast cancer.
    Liu D; Xie G; Chen M
    Int J Clin Oncol; 2014 Apr; 19(2):280-7. PubMed ID: 23640121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival benefit of tamoxifen and aromatase inhibitor in male and female breast cancer.
    Eggemann H; Altmann U; Costa SD; Ignatov A
    J Cancer Res Clin Oncol; 2018 Feb; 144(2):337-341. PubMed ID: 29098396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence and survival outcomes of early male breast cancer: a population-based comparison with early female breast cancer.
    Wang Y; Chen K; Yang Y; Tan L; Chen L; Zhu L; Su F; Liu X; Li S
    Ann Transl Med; 2019 Oct; 7(20):536. PubMed ID: 31807518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival Comparisons Between Early Male and Female Breast Cancer Patients.
    Wang K; Wang QJ; Xiong YF; Shi Y; Yang WJ; Zhang X; Li HY
    Sci Rep; 2018 Jun; 8(1):8900. PubMed ID: 29891971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathological features of male patients with breast cancer based on a nationwide registry database in Japan.
    Shimomura A; Nagahashi M; Kumamaru H; Aogi K; Asaga S; Hayashi N; Iijima K; Kadoya T; Kojima Y; Kubo M; Miyashita M; Miyata H; Niikura N; Ogo E; Tamura K; Tanakura K; Yoshida M; Yamamoto Y; Imoto S; Jinno H
    Breast Cancer; 2022 Nov; 29(6):985-992. PubMed ID: 35733033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of male breast cancer in the United States: a surveillance, epidemiology and end results analysis.
    Fields EC; DeWitt P; Fisher CM; Rabinovitch R
    Int J Radiat Oncol Biol Phys; 2013 Nov; 87(4):747-52. PubMed ID: 24138917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathologic characteristics and prognosis for male breast cancer compared to female breast cancer.
    Yao N; Shi W; Liu T; Siyin ST; Wang W; Duan N; Xu G; Qu J
    Sci Rep; 2022 Jan; 12(1):220. PubMed ID: 34997151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Male Breast Cancer Prognostic Factors Versus Female Counterparts with Propensity Scores and Matched-Pair Analysis.
    Yu E; Stitt L; Vujovic O; Joseph K; Assouline A; Younus J; Perera F; Tai P
    Cureus; 2015 Oct; 7(10):e355. PubMed ID: 26623210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dachshund 1 is Differentially Expressed Between Male and Female Breast Cancer: A Matched Case-Control Study of Clinical Characteristics and Prognosis.
    Cui Q; Kong D; Li Z; Ahiable P; Wang K; Wu K; Wu G
    Clin Breast Cancer; 2018 Oct; 18(5):e875-e882. PubMed ID: 29478945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utility of Oncotype DX in Male Breast Cancer Patients and Impact on Chemotherapy Administration: A Comparative Study with Female Patients.
    Williams AD; McGreevy CM; Tchou JC; De La Cruz LM
    Ann Surg Oncol; 2020 Oct; 27(10):3605-3611. PubMed ID: 32472417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overall Survival of Men and Women With Breast Cancer According to Tumor Subtype: A Population-based Study.
    Leone J; Zwenger AO; Leone BA; Vallejo CT; Leone JP
    Am J Clin Oncol; 2019 Feb; 42(2):215-220. PubMed ID: 30499840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.